DC News Now: New Company “Addimmune” to Focus Exclusively on Developing HIV Cure

CEO Jeff Galvin joins DC News Now reporter Shennekia Grimshaw on-air to discuss the launch of Addimmune™, a new company created to continue developing gene and cell therapy technologies to cure HIV. Addimmune will focus solely on advancing an HIV cure, building upon more than a decade of work by American Gene Technologies® that led to a successful Phase 1 HIV gene and cell therapy clinical trial.

About Addimmune:
Addimmune was founded in 2023 to cure HIV with promising gene therapy technologies. Building upon the success of American Gene Technologies’ HIV clinical trial, Addimmune is solely focused on developing and commercializing an effective and lasting cure for HIV. Learn more about Addimmune in this video:    • Addimmune Pursues a Cure for HIV with...  

Visit our website: https://www.addimmune.com/

Follow Addimmune on social media:

Facebook:   / addimmune  

Twitter:   / addimmune  

LinkedIn:   / addimmune  

Instagram:   / addimmune  

Follow CEO Jeff Galvin on social media:

Jeff Galvin’s Twitter:   / jeffreygalvin  

Jeff Galvin’s LinkedIn:   / jeff-galvin